直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Obviousness of Biologics Inventions: Strategies for Biologics Claims in the United States, Europe, and China

September 5, 2019

Webinar

Strafford Publications

As part of Strafford Publications' webinar series, Finnegan partner Bryan Diner will discuss practices for overcoming the challenges of obviousness in biologics patent claims in the United States, Europe, and China. The program will consider the similarities and differences between claim types that have the best chance of success, and will discuss recent case law and key issues that arise. For more information, or to register, please see Strafford Publications' website.

Tags

China, Obviousness (35 USC § 103)

Related Industries

Life Sciences

Biologics

Related Professionals

Bryan C. Diner
Partner
Washington, DC
+1 202 408 4116
Email

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

Conference

BIA Start-up Festival

May 21, 2026

London

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Seminar

IP Strategy at the Crossroads: Technology, Enforcement, and Contracts

May 15, 2026

Taipei

Panel Discussion

Global Patent Strategies & Litigation: An Exclusive Off-the-Record Conversation with Experienced In-House Leaders

May 5, 2026

London

European IP Blog

T 0137/24 and Securing Effective Protection for Biologics

May 1, 2026

Conference

THRiVE 2026

April 30, 2026

Richmond

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP